Indication
Dystrophic epidermolysis bullosa
Dystrophic epidermolysis bullosa is a rare inherited genodermatosis characterized by extreme mechanical fragility of the skin and mucous membranes, with clinical onset typically occurring at birth or during early infancy. Read more about Dystrophic epidermolysis bullosa
2 drugs 2 manufacturers
Drugs that treat it
Common Dystrophic epidermolysis bullosa therapies.
ZEVASKYN (prademagene zamikeracel)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDystrophic epidermolysis bullosa is a rare inherited genodermatosis characterized by extreme mechanical fragility of the skin and mucous membranes, with clinical onset typically occurring at birth or during early infancy.
Pathophysiologically, the disorder is caused by mutations in the *COL7A1* gene, which leads to a deficiency or defect in type VII collagen, the primary component of anchoring fibrils that secure the epidermal basement membrane to the underlying dermis.
Blistering develops in the sub-lamina densa plane in response to minor friction or trauma, resulting in chronic non-healing erosions, extensive scarring, nail dystrophy, pseudosyndactyly (mitten deformities), and esophageal strictures.
Severe forms, particularly recessive subtypes, are further complicated by chronic systemic inflammation, growth impairment, and a markedly elevated lifetime risk of aggressive cutaneous squamous cell carcinoma.
- nih.gov
Dystrophic epidermolysis bullosa is a rare inherited genodermatosis characterized by extreme mechanical fragility of the skin and mucous membranes, with clinical onset typically occurring at birth or during early infancy Pathophysiologically, the disorder is caused by mutations in the *COL7A1* gene, which leads to a deficiency or defect in type VII collagen, the primary component of anchoring fibrils that secure the epidermal basement membrane to the underlying dermis Blistering develops in the ...
- nih.gov
Blistering develops in the sub-lamina densa plane in response to minor friction or trauma, resulting in chronic non-healing erosions, extensive scarring, nail dystrophy, pseudosyndactyly (mitten deformities), and esophageal strictures Severe forms, particularly recessive subtypes, are further complicated by chronic systemic inflammation, growth impairment, and a markedly elevated lifetime risk of aggressive cutaneous squamous cell carcinoma
Personalize your experience
Follow Dystrophic epidermolysis bullosa and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.